FDA Fast Track For Narmafotinib In Advance Pancreatic Cancer
19 Sep 2024 //
PR NEWSWIRE
FDA Clearance Of Amplia`S Ind For Pancreatic Cancer Trial In Us
17 Jan 2024 //
PR NEWSWIRE
AMP945 Combined with FOLFIRINOX Enhances Treatment Effects Pancreatic Cancer
29 May 2023 //
PR NEWSWIRE
Amplia partners with CSIRO to develop wound healing solutions
23 May 2023 //
BIOSPECTRUM ASIA